Evidence map›Paper›PMID 30572631›Full record

ArticleInternational journal of molecular sciences2018

Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model.

Guohong Qin, Ji Ma, Qiongshan Huang, Hongli Yin, Jichun Han, Maoru Li, Yang Deng, Bing Wang, Waseem Hassan, Jing Shang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Therapeutic potential ofFrontiers in pharmacology · 2025
    Review
  8. Effect of water extract of bay laurel (Food & nutrition research · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Protective Effects ofInternational journal of molecular sciences · 2023
    Article
  16. Review
  17. Article
  18. Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases.Clinical reviews in allergy & immunology · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Guohong QinSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. qinguo_0@163.com.
Ji MaSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. matthewmj@163.com.
Qiongshan HuangSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. h569624132@163.com.
Hongli YinSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. yinhongli141516@163.com.
Jichun HanSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. hanjichun10@163.com.
Maoru LiSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. limaoru2016@163.com.
Yang DengSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. youngd2018@163.com.
Bing WangSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. weibowang2018@163.com.
Waseem HassanDepartment of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore 54000, Pakistan. waseemhassan@cuilahore.edu.pk.
Jing ShangSchool of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. shangjing21cn@cpu.edu.cn.
China Pharmaceutical University · CNCOMSATS University Islamabad · PK

Funding

National Science Technology Major Project of China No. 2018ZX09301030-005The Open Project of State Key Laboratory of Natural Medicines No.3144060130
6 · The paper itself

Abstract

Isoquercetin (IQ), a glucoside derivative of quercetin, has been reported to have beneficial effects in nonalcoholic fatty liver disease (NAFLD). In this study, we investigated the potential improvement of IQ in liver lipid accumulation, inflammation, oxidative condition, and activation in Kupffer cells (KCs) on a high-fat diet (HFD) induced NAFLD models. Male Sprague-Dawley (SD) rats were induced by HFD, lipopolysaccharides/free fatty acids (LPS/FFA) induced co-culture cells model between primary hepatocytes and Kupffer cells was used to test the effects and the underlying mechanism of IQ. Molecular docking was performed to predict the potential target of IQ. Significant effects of IQ were found on reduced lipid accumulation, inflammation, and oxidative stress. In addition, AMP-activated protein kinase (AMPK) pathway was activated by IQ, and is plays an important role in lipid regulation. Meanwhile, IQ reversed the increase of activated KCs which caused by lipid overload, and also suppression of Transforming growth factor beta (TGF-β) signaling by TGF-β Recptor-1 and SMAD2/3 signaling. Finally, TGF-βR1 and TGF-βR2 were both found may involve in the mechanism of IQ. IQ can improve hepatic lipid accumulation and decrease inflammation and oxidative stress by its activating AMPK pathway and suppressing TGF-β signaling to alleviate NAFLD.

Indexed as

AMP-Activated Protein KinasesAnimalsBiomarkersCoculture TechniquesCytokinesDiet, High-FatDisease Models, AnimalDown-RegulationInflammationKupffer CellsLipid MetabolismLiverMaleMolecular Docking SimulationNon-alcoholic Fatty Liver DiseaseOxidative StressAMP-Activated Protein KinasesBiomarkersCytokinesisoquercitrinProtein Serine-Threonine KinasesQuercetinTransforming Growth Factor betaAMPKisoquercetinKupffer cellNAFLDTGF-β

Identifiers

PMID30572631
PMCPMC6321444
OpenAlexW2904753778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.